Skip to main content
. 2022 Jul 22;2022(7):CD008080. doi: 10.1002/14651858.CD008080.pub2

3.6. Analysis.

3.6

Comparison 3: Intratympanic corticosteroids compared to no treatment/placebo as secondary therapy, Outcome 6: Frequency‐specific changes with PTA